Literature DB >> 10767429

Contribution of the different modules in the utrophin carboxy-terminal region to the formation and regulation of the DAP complex.

A Tommasi di Vignano1, G Di Zenzo, M Sudol, G Cesareni, L Dente.   

Abstract

The carboxy-terminal region of utrophin, like the homologous proteins dystrophin, Drp2 and dystrobrevins, contains structural domains frequently involved in protein-protein interaction. These domains (WW, EF hands, ZZ and H1-H2) mediate recognition and binding to a multicomponent complex of proteins, also known as dystrophin-associated proteins (DAPs) for their association with dystrophin, the product of the gene, mutated in Duchenne muscular dystrophy. We have exploited phage display and in vitro binding assays to study the recognition specificity of the different domains of the utrophin carboxy-terminus. We found that none of the carboxy-terminal domains of utrophin, when isolated from its structural context, selects specific ligand peptides from a phage-displayed peptide library. By contrast, panning with an extended region containing the WW, EF hands, and ZZ domain defines the consensus binding motif, PPxY which is also found in beta-dystroglycan, a component of the DAP complex that interacts with utrophin in several tissues. WW-mediated binding to PPxY peptides and to beta-dystroglycan requires the presence of the EF hands and ZZ domain. When the ZZ domain is either deleted or engaged in binding to calmodulin, the utrophin beta-dystroglycan complex cannot be formed. These findings suggest a potential regulatory mechanism by means of which the attachment of utrophin to the DAP complex can be modulated by the Ca(2+)-dependent binding of calmodulin. The remaining two motifs found in the carboxy-terminus (H1-H2) mediate the formation of utrophin-dystrobrevin hybrids but do not select ligands in a repertoire of random nonapeptides.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767429     DOI: 10.1016/s0014-5793(00)01400-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Dp71, utrophin and beta-dystroglycan expression and distribution in PC12/L6 cell cocultures.

Authors:  Ramses Ilarraza-Lomeli; Bulmaro Cisneros-Vega; Maria de Lourdes Cervantes-Gomez; Dominique Mornet; Cecilia Montañez
Journal:  Neuroreport       Date:  2007-10-29       Impact factor: 1.837

2.  ZZ domain of dystrophin and utrophin: topology and mapping of a beta-dystroglycan interaction site.

Authors:  Karim Hnia; Dora Zouiten; Sonia Cantel; Delphine Chazalette; Gérald Hugon; Jean-Alain Fehrentz; Ahmed Masmoudi; Ann Diment; Janice Bramham; Dominique Mornet; Steve J Winder
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

Review 3.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

Review 4.  Dystroglycan: emerging roles in mammary gland function.

Authors:  M Lynn Weir; John Muschler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

5.  Dystrophin-glycoprotein complex sequesters Yap to inhibit cardiomyocyte proliferation.

Authors:  Yuka Morikawa; Todd Heallen; John Leach; Yang Xiao; James F Martin
Journal:  Nature       Date:  2017-06-05       Impact factor: 49.962

6.  Kir2.1 Interactome Mapping Uncovers PKP4 as a Modulator of the Kir2.1-Regulated Inward Rectifier Potassium Currents.

Authors:  Sung-Soo Park; Daniela Ponce-Balbuena; Rork Kuick; Guadalupe Guerrero-Serna; Justin Yoon; Dattatreya Mellacheruvu; Kevin P Conlon; Venkatesha Basrur; Alexey I Nesvizhskii; José Jalife; Jean-François Rual
Journal:  Mol Cell Proteomics       Date:  2020-06-15       Impact factor: 5.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.